Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Balance Labs (BLNC) Common Equity (2016 - 2025)

Balance Labs filings provide 12 years of Common Equity readings, the most recent being -$3.4 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 33.42% to -$3.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.4 million, a 33.42% increase, with the full-year FY2025 number at -$3.4 million, up 33.42% from a year prior.
  • Common Equity hit -$3.4 million in Q4 2025 for Balance Labs, up from -$8.7 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $168584.0 in Q3 2021 to a low of -$8.7 million in Q3 2025.
  • Median Common Equity over the past 5 years was -$4.2 million (2022), compared with a mean of -$4.1 million.
  • Biggest five-year swings in Common Equity: soared 104.9% in 2021 and later tumbled 2451.9% in 2022.
  • Balance Labs' Common Equity stood at -$3.4 million in 2021, then decreased by 22.65% to -$4.2 million in 2022, then decreased by 9.17% to -$4.5 million in 2023, then fell by 11.63% to -$5.1 million in 2024, then surged by 33.42% to -$3.4 million in 2025.
  • The last three reported values for Common Equity were -$3.4 million (Q4 2025), -$8.7 million (Q3 2025), and -$5.2 million (Q2 2025) per Business Quant data.